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FGF8The transcription factor spalt4 is a key early-response gene in otic placode induction. Here, we characterize
the cis-regulatory regions of spalt4 responsible for activation of its expression in the developing otic placode
and report the isolation of a novel core enhancer. Identiﬁcation and mutational analysis of putative
transcription factor binding sites reveal that Pea3, a downstream effector of FGF signaling, and Pax2 directly
activate spalt4 during ear development. Morpholino-mediated knock-down of each factor reduces or
eliminates reporter expression. In contrast, combined over-expression of Pea3 and Pax2 drives ectopic
reporter expression, suggesting that they function synergistically. These studies expand the gene regulatory
network underlying early otic development by identifying direct inputs that mediate spalt4 expression.
© 2009 Elsevier Inc. All rights reserved.Introduction
Ectodermal placodes are transient regions of thickened ectoderm
of the head that contribute to the ear, nose, lens and cranial ganglia
(Baker and Bronner-Fraser, 2001). Of these, the best studied is the otic
placode, which is induced adjacent to the hindbrain by signals
emanating from ﬂanking tissues (Dominguez-Frutos et al., 2009; Kil
et al., 2005; Kwon and Riley, 2009; Ladher et al., 2005; Park and
Saint-Jeannet, 2008). Signals such as FGFs (Leger and Brand, 2002;
Maroon et al., 2002; Vendrell et al., 2000;Wright andMansour, 2003),
Wnts (Freter et al., 2008; Ohyama et al., 2006) and BMPs (Kwon and
Riley, 2009) are involved in otic placode induction (Martin and
Groves, 2006) and activate speciﬁc patterns of gene expression
(Litsiou et al., 2005). For example, over-expression of FGFs induces
ectopic otic-like structures (Alvarez et al., 2003; Kil et al., 2005;
Vendrell et al., 2000), while mutations in FGFs lead to defects in ear
development (Alvarez et al., 2003; Ladher et al., 2005). Following
induction, the columnar placode invaginates to form the otic vesicle,
which subsequently differentiates into the complex inner ear,
including the cochlea, vestibular system and endolymphatic sac.
The transcription factor spalt4, homolog of human SALL4 (Sweetman
and Munsterberg, 2006), displays the correct localization pattern to
be a key early-response gene in placode induction in the chick
(Barembaum and Bronner-Fraser, 2007). It is initially expressed uni-te the 50th anniversary of
aser).
ll rights reserved.formly throughout the head ectoderm, overlapping with Six-Eya-Dach
in the preplacodal domain. It then resolves to the presumptive otic
and olfactory placode regions by stage 10, as non-placodal ectoderm
loses competence to form otic placode (Baker and Bronner-Fraser,
2001; Groves and Bronner-Fraser, 2000). Expression of spalt4 in non-
placodal ectoderm is sufﬁcient to induce invagination or ingression
and expression of a number of otic genes (Barembaum and Bronner-
Fraser, 2007). Interestingly, the effects of its gain- and loss-of-function
resemble those of FGF over-expression and mutations, respectively.
This raises the intriguing possibility that spalt4may be downstream of
FGF and other inductive signals.
Numerous transcription factors in addition to spalt4, including
Pax2 (Mackereth et al., 2005), Dlx3 (Esterberg and Fritz, 2009) and
Dlx5 (Brown et al., 2005; Robledo and Lufkin, 2006), have been
found to play important roles in otic development (Baker and
Bronner-Fraser, 2001). Although the position and function of a few
of these regulators are documented in otic development, their order,
interrelationship and direct or indirect nature of their interactions are
not yet known and currently under investigation (Esterberg and Fritz,
2009; Hans et al., 2007).
To better understand important gene regulatory interactions
underlying ear development, we set out to characterize the cis-
regulatory regions of spalt4 based on its key position in otic placode
induction. We report the isolation and dissection of a novel spalt4
regulatory module, responsible for activation of spalt4 expression in
the developing otic placode. We further interrogate this regulatory
region to identify putative transcription factor binding sites and
upstream regulators controlling its expression. The results reveal that
Pea3, a downstream effector of FGF signaling, and Pax2 directly
Fig. 1. In situ hybridization of chicken embryos with spalt4 RNA probe. (A) Stage 10
embryo showing signal in the otic placode (arrowhead) and presomitic mesoderm
(arrow). (B) Stage 14 embryo showing signal in the otic pits (black arrowhead) and
midbrain (arrow). The region that will give rise to the epiphysis also expresses spalt4
(white arrowhead). Other forebrain staining is background.
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knowledge of known transcription factors and their direct interac-
tions during development of the ear.
Materials and methods
Cloning
Regions of non-coding genomic DNA in the vicinity of the spalt4
(Sall4) coding region were compared between chick and other
vertebrates. Conserved regions were ampliﬁed from the BAC clone
CH261-71D2 (BPRC, Oakland Research Institute, Oakland, CA) and
cloned into the pTK vector in front of a minimal TK promoter
driving GFP expression (Uchikawa et al., 2004). Mutations were
made by fusion PCR (Heckman and Pease, 2007). For over-ex-
pression experiments, the protein coding regions of chicken Pea3
and Pax2 were ampliﬁed by RT-PCR and cloned into the pCIG
vector. Cerulean ﬂuorescent protein was cloned into the pCAGS
expression vector.
Electroporation
Stage 4–6 embryos were collected on Whatman ﬁlter rings and
placed ventral side up in an electoporation chamber, with negative
electrode at the bottom. Plasmid DNA, either at 1 mg/ml for enhancer
constructs or 2 mg/ml for over-expression constructs, was injected
through the blastoderm into the space between the embryo and the
vitelline membrane. The positive electrode was placed above the
embryo and an electric currentwas applied of four pulses of 7 V, 50ms
in duration with a 100 ms pause in between pulses. After electro-
poration, embryos were transferred ventral side up to a 35 mm dish
with a thin layer of egg albumin at the bottom and incubated in a
humidiﬁed incubator at 37 °C for 24 h (Sauka-Spengler and
Barembaum, 2008). Those embryos with high levels of ﬂuorescence,
indicating efﬁcient eletroporation, were ﬁxed in 4% formaldehyde
overnight. Morpholino oligos were obtained from Gene-Tools (Philo-
math, OR) and dissolved in water at 1 or 3 mM concentrations.
Plasmid DNA (pUC19) was added at a ﬁnal concentration of 100 ng/μl
prior to injecting into embryos. In order to electroporate the
morpholino at 3 mM, the embryos were ﬁrst electroporated with
the enhancer construct then followed by the morpholino. The
ﬂuoresceinated morpholino oligos were made with the following
sequence:
Pea3: 5′-CTG CTG GTC CAC GTA CCC CTT CAT C-3′
Pax2: 5′-GTC TGC CTT GCA GTG CAT ATC CAT G-3′
Control: 5′-CCT CTT ACC TCA GTT ACA ATT TAT A-3′
Implantation of beads
Stage 4 embryos were collected onWhatman ﬁlter paper rings and
turned ventral side up in Ringer's solution and electroporated as
described above. A small slit was made in the area opaca next to the
area pellucida (Litsiou et al., 2005). A bead soaked in 50 µg/ml Fgf8
(R&D Systems, Minneapolis MN) or BSA (bovine serum albumin) was
inserted into the slit and incubated in modiﬁed New culture
(Chapman et al., 2001) for 5–7 h and then collected and ﬁxed
overnight in 4% paraformaldehyde.
Analysis of embryos
Embryos were collected in Ringer's solution and ﬁxed in 4%
paraformaldehyde overnight. Embryos were washed in PBT and
embedded in gelatin for histochemical analysis or dehydrated in
methanol for in situ hybridization. In situ hybridization was
performed as described previously (Wilkinson, 1992). Antibodies toGFP (Abcam), Pax2 (Zymed), and ﬂuorescein (Roche) were obtained
commercially. Primary antibodies were visualized with Alexa Fluor
488-conjugated donkey anti-goat or Alexa Fluor 594-conjugated
donkey anti-rabbit secondary antibodies (Molecular Probes). Cerule-
an ﬂuorescent protein expression was distinguished from ﬂuorescein
signal using a Zeiss 510 META 2 inverted microscope.
Results
Dissection of putative spalt4 regulatory region
Spalt4 is initially expressed throughout the preplacodal domain
but resolves to the otic placode by stages 9–10 (Fig. 1A) (Barembaum
and Bronner-Fraser, 2007). By stage 14, it is robustly expressed in
the otic pit and maintained during formation of the otic vesicle
(Fig. 1B). We set out to identify enhancer elements capable of driving
reporter expression that recapitulated this spatiotemporal expression
pattern.
To identify the cis-regulatory elements responsible for spalt4
expression in developing ear, we probed the genomic region sur-
rounding the spalt4 gene using comparative genomic analysis to
isolate highly conserved genomic regions with putative regulatory
activity. For our study, non-coding genomic regions upstream of the
spalt4 coding region and the ﬁrst intron were compared in silico
using the UCSC gene browser (Fig. 2A) (Karolchik et al., 2008).
Fragments 1 to 5 kb in size containing the putative regulatory regions
with the highest homology were ampliﬁed from a chicken BAC clone
and cloned into an EGFP reporter vector containing a thymidine
kinase basal promoter (Uchikawa et al., 2004).
The spalt4 gene is located on chicken chromosome 20 between
genes ZFP64 and ATP9A. Because the May 2006 version of the
chicken genome did not contain the sequence of the ﬁrst exon, we
cloned the DNA corresponding to a gap in the sequence from a BAC
using GC rich PCR. This region contained the ﬁrst exon of spalt4. At
the 5′ end there is over 100 kb of sequence between spalt4 and
ZFP64. We cloned several conserved regions upstream of the coding
region, as well as within the ﬁrst intron, which induced GFP
Fig. 2. Isolation of conserved regions adjacent to chicken spalt4. (A) Map of the region adjacent to spalt4. The peaks show regions of conservation. The dark bands below each peak
show the regions conserved between chicken and each of the other species examined. The red letters above each peak identify the regions that were cloned. Spalt4 coding region is at
the extreme right of the map. (B–G) Enhancer activity of conserved region F (CR-F). (B) At stage 9, CR-F drives expression in the lateral plate mesoderm (arrowhead). (C) At stage 10
CR-F drives GFP in the otic placode (arrowhead). (D) A section through a stage 10 embryo electroporated with CR-F shows that the otic placode (arrowhead) and the lateral plate
mesoderm express GFP. (E) Stage 12 embryo with GFP in the otic pits (arrowhead) and lateral plate mesoderm (arrow). (F) Stage 14 embryo shows GFP expression in the otic vesicle
(arrowhead), epibranchial placodes (large arrow) and the midbrain (small arrow). (G) Section through a stage 14 embryo showing GFP expression in the otic vesicles (arrowhead).
Each embryo was co-electroporated with pCIG-RFP as an electroporation control.
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Conserved Region (CR) A-I (Fig. 2A).
To test if the conserved genomic regions were functional in vivo,
they were individually electroporated into stage 4 chick embryos
using an ex ovo technique (Uchikawa et al., 2004). Electroporation
efﬁciency was assessed by co-electroporating a pCIG mRFP plasmid
construct under control of a ubiquitous promoter. Embryos were
collected 24–48 h (stages 10–20) after electroporation, ﬁxed and
analyzed for EGFP expression using ﬂuorescence microscopy. Of
the genomic regions analyzed, 13 had some enhancer activity, des-cribed below, though only CR-F had expression in the otic placode
(Figs. 2B–G).
Identiﬁcation of spalt4 genomic fragment with regulatory activity in the
developing otic placode and other embryonic locations
The 1.3 kb fragment CR-F was conserved between chicken and
mammals, but displayed no conservation with Xenopus or zebraﬁsh.
When electroporated into chicken embryos, CR-F drove GFP
expression in the otic placode at stage 10 (Figs. 2C, D) with
225M. Barembaum, M. Bronner-Fraser / Developmental Biology 340 (2010) 222–231continued expression in the otic pit (Fig. 2E) and later in the otic
vesicle (Figs. 2F, G) at least until stage 17. GFP was observed in the
otic region as well as the contiguous lateral ectoderm that will give
rise to the epibranchial placodes (Figs. 2F, G). In addition it drove
expression in the lateral plate mesoderm (Figs. 2B–E) and midbrain
(Fig. 2F). The GFP in lateral plate mesoderm, which includes both
the somatic and splanchnic mesoderm was expressed at least as
early as stage 8 and included the heart ﬁeld (Fig. 2A). The
expression of GFP then became restricted caudally, so that it was
only seen in the caudal trunk region at stage 12 (Fig. 2E), but not in
the developing heart after stage 9 (Fig. 2B).
CR-A, CR-B, CR-E and CR-H induced GFP expression only in the
blood islands, at the times and regions tested (data not shown).
Two conserved regions besides CR-F drove expression of GFP in the
trunk mesoderm. CR-89 was expressed in the intermediate
mesoderm (Fig. 3A) and later in the developing pronephros. CR-C
induced strong GFP expression in the presomitic mesoderm and
the caudal somites (Fig. 3D). Several other conserved regions
displayed complex expression patterns in the neural tube. CR-101
drove expression in the caudal neural tube, including the future
hindbrain at stage 10, but only in the spinal cord at stage 12 and
later (Fig. 3B). CR-C induced GFP throughout the neural tube
(Fig. 3C) until stage 12 after which time GFP expression was
reduced. CR-G expressed GFP in the midbrain, rostral hindbrain
and rostral spinal cord, as well as in the presomitic mesoderm
(Fig. 3E). In sections, only the ventral neural tube had GFP ex-
pression (data not shown). The most distal element, CR-I drove
expression of GFP in the neural tube, though signiﬁcantly higher
expression was found in the hindbrain (Fig. 3F). Thus, much of the
embryonic expression of spalt4 was recapitulated by the combinedFig. 3. Enhancer activity in other mesoderm and neural tube. (A) Conserved region 89 (CR
the caudal CNS (arrowhead). (C) CR-C in the neural tube (arrowhead). (D) CR-D in the pres
and the spinal cord (arrow). (F) CR-I drove expression most strongly in the hindbrain (a
control.activity of the isolated enhancers. However, we were unable to
detect a neural crest enhancer.
Dissection of the CR-F fragment reveals a minimal enhancer region
To better understand regulatory interactions underlying ear
development, we further interrogated the CR-F fragment to deter-
mine a minimal otic enhancer element. For this purpose, we used PCR
to generate a number of deletion constructs (Fig. 4). A highly con-
served 752 bp subfragment (F14) retained both otic and mesodermal
expression, similar to intact CR-F. Removing the 5′ 71 base pairs
reduced GFP level in the otic placode and eliminated lateral meso-
derm expression. Removing the 200 base pairs at the 3′ end reduced
the mesoderm expression. Removing an additional 88 base pairs
reduced the otic expression and eliminated the mesodermal expres-
sion. Loss of both the 5′ 71 base pairs and 3′ 200 base pairs eliminated
all expression.
The minimal fragment found to drive strong otic expression was
551 bp in length. Otic expression appears to depend on several
regions spread along the length of this fragment. To determine
putative transcription factor binding sites that could be tested by
mutational analysis, we turned to a bioinformatics analysis.
Identiﬁcation of transcription factor binding sites in CR-F
Examination of the 752 bp conserved sequence of CR-F using the
JASPAR database (Wasserman and Sandelin, 2004) revealed a number
of putative transcription factor recognition sites (Fig. 5). Of thosemost
relevant to otic development, we found several potential Pax2 binding
sites, as well as a number of putative Ets transcription factor binding-89) drove GFP expression in the intermediate mesoderm (arrowhead). (B) CR-101 in
omitic mesoderm and the somites (arrowhead) (E) CR-G in the midbrain (arrowhead)
rrowhead). Each embryo was co-electroporated with pCIG-RFP as an electroporation
Fig. 4.Deletions made to CR-F. The level of conservation is seen at the top. Each deletion is identiﬁed by its location in the sequence in Fig. 5. They were qualitatively assessed for their
ability to drive expression in the otic placode (otic) or lateral plate mesoderm (meso) to determine whether they had the same level as the full length (F14) construct, ++, had a
reduced level, +, or an undetectable level (−).
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known to act as downstream effectors of FGF signaling (Raible and
Brand, 2001; Roehl and Nusslein-Volhard, 2001). Since Pax2 (Groves
and Bronner-Fraser, 2000) and Pea3 (Lunn et al., 2007) both are
expressed early in otic development, they represented good candi-
dates for regulating expression of spalt4 in the otic placode.
To test whether the putative Pax2 and the Pea3 binding sites are
necessary for enhancer activity, a number of mutations were made in
a minimal enhancer element by replacing the putative binding
sequences by heterologous GFP sequences of the same size. The
mutations were performed in the deletion construct CR-F12 since it
maintains otic expression, though the mesodermal enhancer activity
is reduced. We targeted both remaining Pea3 sites as well as the two
Pax2 sites (Fig. 6A). Mutation of the upstream putative Pea3 site
(MutH, nucleotides 142–147 in Fig. 5) resulted in loss of otic enhancer
activity (Figs. 6F–I). We noted a reduction of otic enhancer activity by
mutating the Pax2 sites (MutG, 348–368), but not the intervening
Pea3 site (351–358) (Figs. 6D, E). The requirement for both the
upstream Pea3 site and the Pax2 sites suggests a possible synergistic
interaction between these two sites. If the F14 (1–752) construct has
the mutation that removes both of the Pax2 sites and the intervening
Pea3 site, otic enhancer activity is retained (data not shown). Thismay
be due to the presence of additional transcription binding sites that
also have activity. We determined that the Pea3 site is required in theFig. 5. The sequence of CR-F14. Some of the consensus transcrilarger fragment (Figs. 6H, I). Interestingly, the enhancer activity in the
midbrain is unaffected by mutating the Pea3 site (data not shown).
Mutations to other putative recognition sites, Otx and Tcf/Lef, have
little or no effect on otic enhancer activity. However, these sites may
be important for expression in other regions or at times other than
those examined.
Additionally, using the CR-F14 construct that contains the full
conserved region, we have identiﬁed a putative Tbx binding site (512–
520) that is required for enhancer activity in the lateral plate
mesoderm. Mutating this region resulted in the loss of enhancer
activity in the lateral plate mesoderm (data not shown).
Ectopic FGF, Pea3 or Pax2 induce CR-F expression
The Ets transcription factors Pea3 and Erm are both expressed in
the otic placode and are part of the FGF signaling pathway (Lunn et al.,
2007). To test if CR-F could be activated by FGF, we inserted beads
soaked in FGF8 in the area opaca adjacent to the area pellucida in
stage 4 embryos that had been previously electroporated with a CR-F
pTK construct. In these embryos, the cells surrounding the beads
expressed GFP, indicating that FGF can induce the activity of the CR-F
enhancer (Fig. 7). Previously, in situ hybridization revealed spalt4
transcripts were induced in the cells surrounding FGF coated beads
(Barembaum and Bronner-Fraser, 2007). Electroporation of Pea3ption factor recognition sites are shaded for identiﬁcation.
Fig. 6. Mutational analysis of CR-F12. (A) Two different mutation constructs were
made. MutH had a mutation in the Pea3 site located at 142–147. MutG mutated both
Pax2 sites between 348 and 368 and the Pea3 site at 351–356 was not mutated
(dotted line under the sequence). Embryos were co-electroporated with the mutant
constructs driving GFP (D,F,H) and non-mutant constructs driving Cherry ﬂuorescent
protein (C, E, G, I) as controls. Arrows point to the otic placode. (B) Embryo electro-
porated with the non-mutated CR-F12 driving GFP had otic expression. (C) Embryo in
(B) showing comparable levels of Cherry. (D) MutG construct showing much reduced
levels of GFP in the otic compared to (E). (F) F12MutH construct had undetectable
levels of GFP in the otic while the control had normal levels (G). (H) F14MutH had
undetectable levels of GFP in the otic, while the F14 control had normal levels (I).
Fig. 7. FGF8 induced CR-F activity. Embryos were electroporated with CR-F-pTK and
pCIG-RFP. Beads soaked in FGF8 (A,B) or BSA (C,D) were implanted in the area opaca.
(A) Ectoderm above the FGF8 soaked beads (arrowheads) contained GFP. (B) Same
embryo as in (A) showing broad RFP as an electroporation control. The positions of the
beads are outlined. (C) Ectoderm above a BSA soaked bead (arrowhead) had no visible
GFP positive cells. (D) Same embryo as in (C) showing the cells above the bead were
electroporated (arrowhead). The position of the bead is outlined.
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caused ectopic Cherry expression co-localized in the extraembryonic
ectoderm with ectopic Pea3 expression (Figs. 8A, B). However, Pea3
over-expressing cells in the embryonic ectoderm did not induce
enhancer activity over the embryo. Thus the ability of Pea3 to induce
enhancer activity is limited.
To further study the effect of Pax2 on CR-F induction in the ear, we
electroporated a Pax2 expression construct and a pTK construct using
CR-F12 driving the expression of Cherry ﬂuorescent protein in the
ectoderm. In these experiments, the reporter expression reﬂected the
extent of Pax2 misexpression in the extraembryonic ectoderm (Figs.
8C, D). We also noted ectopic Cherry expression in the caudal
hindbrain ectoderm, but did not detect Cherry ﬂuorescent protein in
the rostral head or in the trunk ectoderm. Ectopic Pax2 can thus drive
ectopic CR-F induction of GFP only in limited regions of the embryo. In
situ hybridization with a spalt4 mRNA probe showed that these
regions with ectopic Pax2 and CR-F12 driven Cherry expression also
expressed spalt4 transcript (Supplementary Figure 1A).
Since the mutation experiments show that both Pax2 and Pea3
binding sites are required for CR-F12 activity, we co-electroporated
Pax2 and Pea3 expression constructs along with the reporter. This
resulted in Cherry expression in cells expressing Pax2 and Pea3 at all
rostrocaudal levels, even in the trunk ectoderm that does not
normally form sensory placode cells (Figs. 8E–H). The combination
of Pax2 and Pea3 misexpression yielded much broader enhancer
activity than the sum of the effects of Pax2 and Pea3 over-expression
individually, demonstrating synergism between Pax2 and Pea3 in CR-
F enhancer activity.
Effects of Pea3 and Pax2 antisense morpholinos on CR-F expression and
endogenous ear development
To study the loss-of-function effect of Pea3, we used a morpholino
oligomer to knockdown expression of Pea3 in the otic placode.
Electroporation of 1 mM Pea3 morpholino, directly tagged with
ﬂuorescein, along with the CR-F12 enhancer construct resulted in the
Fig. 8. Pea3 and Pax2 can induce CR-F activity in the extraembryonic ectoderm and together can induce CR-F activity throughout the embryo. Embryos co-electroporated with
Pea3pCIG and CR-F12 Cherry (A, B), Pax2pCIG and CR-F12 Cherry (C, D) and Pea3pCIG, Pax2pCIG and CR-F12 Cherry (E-H). (A) Pea3 expressed throughout the embryo. (B) Cherry
driven by CR-F was expressed in the otic placode and in the extraembryonic ectoderm (arrowhead). (C) Pax2 was expressed throughout the embryo. (D) Cherry driven by CR-F was
expressed in the otic placode and the extraembryonic ectoderm (arrowhead). (E, G) Combined expression of Pea3 and Pax2 throughout the ectoderm. (F, H) Cherry driven by CR-F
was detected in the trunk ectoderm (arrow) as well as the extraembryonic ectoderm (arrowhead). (E) and (F) are lowermagniﬁcation pictures of the embryo in (G) and (H). The otic
placode is outlined in (B), (D), (F), and (H).
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development. In contrast, embryos electroporated with control mor-
pholino plus CR-F12-Cherry retained enhancer activity (Figs. 9A–D)
and normal appearing otic placodes.
The morpholino to Pax2 was effective at 3 mM concentrations,
resulting in a reduction of Pax2 protein as assayed of using an anti-
Pax2 antibody. Cells containing high levels of morpholino, as
determined by the amount of ﬂuorescein signal, did not contain
Pax2 protein (data not shown). As expected, Pax2 morpholino
resulted in some defects in ear development. The placodes on the
morpholino-electroporated side were much thinner than the untreat-
ed side, and failed to invaginate. We noted that electroporations of
3 mM morpholino resulted in a decrease of enhancer activity in
control and experimental embryos (data not shown), likely due to the
high morpholino concentration reducing the efﬁciency of plasmid
transfection. To circumvent this problem, we electroporated the
enhancer construct ﬁrst, followed by the morpholino electroporation.
Cells that received high levels of Pax2 morpholino lacked strong F12
enhancer activity (Figs. 9I–K). Since not every cell that is transfected
with the morpholino is also transfected by the enhancer construct we
co-electroporated a ubiquitous Cerulean expression construct with
the F12 enhancer reporter followed by a second electroporation with
the ﬂuorescein tagged Pax2 morpholino. We were able to detect that
cells that had Cerulean expression and ﬂuorescein labeling had no
expression from the F12 enhancer reporter. We also found that most
cells expressing Cerulean and Cherry did not have high levels of
ﬂuorescein tagged Pax2 Morpholino (Figs. 9L–O). With control
morpholino, however, many cells with high levels of control
ﬂuorescein tag had high F12 enhancer activity (Figs. 9A–D). Thus,
cells that contain high levels of Pax2 morpholinos, lacking Pax2
protein, also lack enhancer activity, whereas cells with lower levels ofPax2 morpholino, as seen by lower ﬂuorescein levels, had some
reporter expression. Spalt4 in situ hybridization also shows reduced
expression in the otic placode of the morphant embryos (Supple-
mentary Fig. 1B). These results are consistent with our experiments
with the mutated Pax2 sites that show that Pax2 is necessary for CR-F
enhancer activity in the ear.
Discussion
In depth analysis of the conserved regulatory regions of a key
early-response gene in placode induction has provided important
information regarding the gene regulatory inputs involved in chick
otic development. By dissecting the chick spalt4 enhancer, we show
that the synergistic input of two transcription factors, Pea3 and Pax2,
drives spalt4 expression in the developing otic placode. Spalt4, which
itself plays a role in otic formation, is expressed early in the placode
and later in the otic vesicle. Like FGFs, ectopic spalt4 is sufﬁcient to
cause non-placodal ectoderm to invaginate and form vesicles that
express many of the genes characteristic of the ear (Barembaum and
Bronner-Fraser, 2007).
Precursors for all the paired sensory placodes, including the otic
placode, are derived from the preplacodal domain, a horseshoe
shaped region surrounding the anterior neural plate and marked by
Six-Eya gene expression (Schlosser, 2006; Streit, 2007). Later, FGF
signaling induces ectodermal cells within the preplacodal region to
form otic placode (Martin and Groves, 2006). The source of inductive
signals appears to emanate from both the hindbrain (Kil et al., 2005;
Park and Saint-Jeannet, 2008) and underlying mesoderm (Kwon and
Riley, 2009; Ladher et al., 2005). Studies in several species show that
FGFs have the proper spatiotemporal distribution to be involved in
otic placode induction (Schimmang, 2007). In the chick, FGF8 (Ladher
Fig. 9.Morpholino oligos to Pax2 and Pea3 reduce CR-F activity in the otic placode. (A) Fluorescein in embryo treated with 3 mM control morpholino. (B) Embryo in (A) showing CR-
F enhancer activity driving Cherry ﬂuorescent protein expression. (C) Higher magniﬁcation of (A) showing cells with high levels of control morpholino (arrowhead). (D) Same
region as in (C) showing the cells with high levels of control morpholino had high levels of CR-F activity (arrowhead). (E) Fluorescein in embryo treated with 1mM Pea3morpholino.
(F) Embryo in (E) showing CR-F12 enhancer activity driving Cherry ﬂuorescent protein expression. (G) Higher magniﬁcation of (A) showing cells with either high levels of Pea3
morpholino (arrowhead) or low levels (arrow). (H) Same region as in (G) showing the cells with high levels of Pea3morpholino had low levels of CR-F activity (arrowhead) and cells
with low levels of morpholino had high levels of CR-F activity (arrow). (I) Fluorescein in embryo treated with 3 mM Pax2 morpholino. (J) Embryo in (I) showing CR-F enhancer
activity driving Cherry ﬂuorescent protein expression. (K) Merged image of (I) and (J). Arrows in (I–K) show cells with high enhancer activity and low levels of ﬂuorescein tagged
Pax2 morpholino. Arrowheads point to cells with high morpholino levels and low enhancer activity. (L–O) Embryo electroporated with F12 Cherry enhancer reporter construct and
Cerulean ubiquitous expression vector followed by a second electroporation with ﬂuorescein tagged Pax2 morpholino and imaged with a Zeiss 510 META inverted microscope. (L)
Fluorescein signal showing cells that contained the Pax2 morpholino. (M) Cherry signal showing cells that have F12 enhancer activity. (N) Cerulean signal showing the cells that
were electroporated. (O) Merged image of (L–N). Arrowheads in (L–O) point to a cell that had high levels of ﬂuorescein tagged morpholino had little enhancer activity though still
expressing Cerulean. Arrow points to a cell with high level of enhancer activity and Cerulean expression, but had low levels of ﬂuorescein tagged morpholino.
229M. Barembaum, M. Bronner-Fraser / Developmental Biology 340 (2010) 222–231et al., 2005) and FGF19 (Ladher et al., 2000) are expressed in the
mesoderm and FGF3 in the hindbrain (Mahmood et al., 1996).
Furthermore, adding ectopic FGF3, 19 and 8 can induce ectopic
vesicles and expand the otic vesicles (Kil et al., 2005; Vendrell et al.,2000). Inhibition of FGF signaling blocks Pax2 expression (Martin and
Groves, 2006) and knockdown of FGF8 or FGF3 reduces or eliminates
the otic placode (Ladher et al., 2005; Zelarayan et al., 2007). FGF
signaling activates the Ets genes, Pea3 and Erm, through the action of
230 M. Barembaum, M. Bronner-Fraser / Developmental Biology 340 (2010) 222–231the MAP kinase ERK (Raible and Brand, 2001; Roehl and Nusslein-
Volhard, 2001; Firnberg and Neubuser, 2002). Both Pea3 and Erm
transcription factors are expressed in the otic placode (Lunn et al.,
2007), and thus may be involved in transcriptional control of
downstream genes.
Similarly, genes of the Pax2/5/8 family are expressed in the
developing otic placode (Groves and Bronner-Fraser, 2000; Lawoko-
Kerali et al., 2002; Pfeffer et al., 1998). In mice, Pax8 is expressed
earliest followed by Pax2. In zebraﬁsh, loss of Pax8 leads to defects in
otic induction that are enhanced by also reducing FGF signaling;
furthermore, loss of Pax8 combined with loss of Pax2a and Pax2b
results in loss of the otic vesicle (Mackereth et al., 2005). In zebraﬁsh,
Pax2 and Pax8 may be downstream of Foxi1 and Dlx3b (Hans et al.,
2004). However, knockout mice lacking Pax8 have no apparent otic
phenotype (Mansouri et al., 1998), whereas Pax2 knockouts present
agenesis of the cochlea and vestibuloacoustic ganglia (Torres et al.,
1996).
The present results show that a non-coding region of spalt4
conserved between mammals and birds (CR-F) is sufﬁcient to drive
reporter expression that recapitulates endogenous spalt4 in the otic
placode at stage 10 and later in the otic vesicle. Similarly, expression
of spalt4 in the CNS can be recapitulated by the sum of at least four
separate conserved regions, each of which is responsible for a distinct
subset of expression patterns in the brain and spinal cord. There are
also three different regions that have enhancer activity in different
mesodermal regions.
The CR-F region contains a number of consensus transcription
factor binding sites for potential regulators of otic placode genes:
Pea3/Erm which are effectors of FGF signaling, Pax2 which is
expressed in the ectoderm prior to its thickening into the otic
placode, and TCF-Lef which is a component of the Wnt signaling
pathway. While mutation of the TCF-Lef site had no apparent effect on
reporter expression, mutations of either the Pax2 sites or the
upstream Pea3/Erm site reduced or abolished enhancer activity in
the otic placode and vesicle. Thus, each site is necessary for activity
and they appear to act synergistically.
While we have shown that the Pax2 and Pea3/Erm binding sites
are required, we cannot exclude the possibility that other binding
sites and other transcription factors are also involved in activation of
CR-F otic enhancer activity. To address whether the endogenous
transcription factors are required for the enhancer activity, we
performed loss-of-function analysis. Accordingly, a Pea3 morpholino
completely eliminated enhancer activity. Similarly, cells electropo-
rated with high levels of the Pax2 morpholino also lacked CR-F
activity. In addition, both Pea3 and Pax2 morpholinos reduced the
levels of the endogenous spalt4mRNA. These data are consistent with
the mutational experiments in suggesting that Pea3 and Pax2 are
direct inputs to the CR-F enhancer.
Furthermore, Pea3 and Pax2 can induce CR-F activity when
expressed in ectopic locations such as the extraembryonic ectoderm.
We can also detect CR-F activity in the hindbrain level ectoderm caudal
to the otic placode when Pax2 is over-expressed in this location.
However, many regions of the embryo, such as the trunk, do not have
CR-F activity when Pax2 or Pea3 are expressed by themselves.
Simultaneous electroporation of both Pax2 and Pea3 expression
constructs results in ectopic CR-F enhancer activity in the trunk
ectoderm and throughout the hindbrain level ectoderm. Thus, Pax2
and Pea3 together are sufﬁcient to induce ectopic CR-F throughout the
embryo,whereas neither alone is sufﬁcient. This supports the idea that
these two transcription factors act synergistically.
In summary, we have interrogated the regulatory region of a key
gene involved in speciﬁcation of the otic placode. Our results place the
synergistic interaction of Pax2 and Pea3 directly upstream of spalt4,
which in turn feeds back to activate Pax2 (Barembaum and Bronner-
Fraser, 2007). Establishing direct inputs into the regulatory region of
spalt4 that drives its otic expression provides important insightsinto the gene regulatory network underlying induction of the chick
inner ear.
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